Generation and use of alternative multimers of peptide/MHC complexes

Journal of Immunological Methods

Volumn 268, Issue 1, 2002, Pages 83-92

  Hugues, Stéphanie ^a   Malherbe, Laurent ^a   Filippi, Christophe ^a   Glaichenhaus, Nicolas ^a  

^a CNRS   (France)

Author keywords

Major Histocompatibility Complex (MHC); Multimers; Oligomers; T lymphocytes; Tetramers

Indexed keywords

CHROMIUM; CROSS LINKING REAGENT; CYTOKINE; DIMER; MAJOR HISTOCOMPATIBILITY ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MONOMER; OLIGOMER; PEPTIDE; POLYMER; STAPHYLOCOCCUS PROTEIN A; STREPTAVIDIN; T LYMPHOCYTE RECEPTOR; TETRAMER;

ANTIGEN BINDING; ANTIGEN SPECIFICITY; ANTIGEN STRUCTURE; BIOTINYLATION; CELL PROLIFERATION; CYTOKINE RELEASE; FLOW CYTOMETRY; GENE EXPRESSION SYSTEM; HUMAN; IMMUNOASSAY; IMMUNOCHEMISTRY; IN VITRO STUDY; MAJOR HISTOCOMPATIBILITY COMPLEX; NONHUMAN; PRIORITY JOURNAL; REVIEW; STAINING; T LYMPHOCYTE;

ANIMALS; CROSS-LINKING REAGENTS; ESCHERICHIA COLI; FLOW CYTOMETRY; HISTOCOMPATIBILITY ANTIGENS CLASS I; HISTOCOMPATIBILITY ANTIGENS CLASS II; HUMANS; MICE; MODELS, MOLECULAR; PROTEIN STRUCTURE, QUATERNARY; RECOMBINANT FUSION PROTEINS; STAINING AND LABELING; STAPHYLOCOCCAL PROTEIN A; T-LYMPHOCYTES;

EID: 0036801822     PISSN: 00221759     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-1759(02)00202-8     Document Type: Article

References (36)

1. Abastado J.P., Lone Y.C., Casrouge A., Boulot G., Kourilsky P. Dimerization of soluble major histocompatibility complex-peptide complexes is sufficient for activation of T cell hybridoma and induction of unresponsiveness. J. Exp. Med. 182:1995;439-447.
2. Altman J.D. Phenotypic analysis of antigen-specific T lymphocytes. Science. 280:1998;1821.
3. Appel H., Gauthier L., Pyrdol J., Wucherpfennig K.W. Kinetics of T-cell receptor binding by bivalent HLA-DR peptide complexes that activate antigen-specific human T-cells. J. Biol. Chem. 275:2000;312-321.
4. Bodinier M., Peyrat M.A., Tournay C., Davodeau F., Romagne F., Bonneville M., Lang F. Efficient detection and immunomagnetic sorting of specific T cells using multimers of MHC class I and peptide with reduced CD8 binding. Nat. Med. 6:2000;707-710.
5. Boniface J.J., Rabinowitz J.D., Wulfing C., Hampl J., Reich Z., Altman J.D., Kantor R.M., Beeson C., McConnell H.M., Davis M.M. Initiation of signal transduction through the T cell receptor requires the multivalent engagement of peptide/MHC ligands. Immunity. 9:1998;459-466.
6. Burrows G.G., Bebo B.F. Jr., Adlard K.L., Vandenbark A.A., Offner H. Two-domain MHC class II molecules form stable complexes with myelin basic protein 69-89 peptide that detect and inhibit rat encephalitogenic T cells and treat experimental autoimmune encephalomyelitis. J. Immunol. 161:1998;5987-5996.
7. Burrows G.G., Chang J.W., Bachinger H.P., Bourdette D.N., Offner H., Vandenbark A.A. Design, engineering and production of functional single-chain T cell receptor ligands. Protein Eng. 12:1999;771-778.
8. + T cells by HLA-DR1 oligomers is dependent on the T cell activation state. J. Immunol. 166:2001;741-745.
9. Casares S., Bona C.A., Brumeanu T.D. Engineering and characterization of a murine MHC class II-immunoglobulin chimera expressing an immunodominant CD4 T viral epitope. Protein Eng. 10:1997;1295-1301.
10. Casares S., Zong C.S., Radu D.L., Miller A., Bona C.A., Brumeanu T.D. Antigen-specific signaling by a soluble, dimeric peptide/major histocompatibility complex class II/Fc chimera leading to T helper cell type 2 differentiation. J. Exp. Med. 190:1999;543-553.
11. Casares S., Stan A.C., Bona C.A., Brumeanu T.D. Antigen-specific downregulation of T cells by doxorubicin delivered through a recombinant MHC II-peptide chimera. Nat. Biotechnol. 19:2001;142-147.
12. Cochran J.R., Stern L.J. A diverse set of oligomeric class II MHC-peptide complexes for probing T-cell receptor interactions. Chem. Biol. 7:2000;683-696.
13. Cochran J.R., Cameron T.O., Stern L.J. The relationship of MHC-peptide binding and T cell activation probed using chemically defined MHC class II oligomers. Immunity. 12:2000;241-250.
14. Cochran J.R., Cameron T.O., Stone J.D., Lubetsky J.B., Stern L.J. Receptor proximity, not intermolecular orientation, is critical for triggering T-cell activation. J. Biol. Chem. 276:2001;28068-28074.
15. Crawford F., Kozono H., White J., Marrack P., Kappler J. Detection of antigen-specific T cells with multivalent soluble class II MHC covalent peptide complexes. Immunity. 8:1998;675-682.
16. Cullen C.M., Jameson S.C., DeLay M., Cottrell C., Becken E.T., Choi E., Hirsch R. A divalent major histocompatibility complex/IgG1 fusion protein induces antigen-specific T cell activation in vitro and in vivo. Cell. Immunol. 192:1999;54-62.
17. Dal Porto J., Johansen T.E., Catipovic B., Parfiit D.J., Tuveson D., Gether U., Kozlowski S., Fearon D.T., Schneck J.P. A soluble divalent class I major histocompatibility complex molecule inhibits alloreactive T cells at nanomolar concentrations. Proc. Natl. Acad. Sci. 90:1993;6671-6675.
18. Das C., Mainwaring R., Langone J.J. Separation of complexes containing protein A and IgG or Fc gamma fragments by high-performance liquid chromatography. Anal. Biochem. 145:1985;27-36.
19. Davis M.M., Boniface J.J., Reich Z., Lyons D., Hampl J., Arden B., Chien Y. Ligand recognition by alpha beta T cell receptors. Annu. Rev. Immunol. 16:1998;523-544.
20. Ferlin W., Glaichenhaus N., Mougneau E. Present difficulties and future promise of MHC multimers in autoimmune exploration. Curr. Opin. Immunol. 12:2000;670-675.
21. Greten T.F., Slansky J.E., Kubota R., Soldan S.S., Jaffee E.M., Leist T.P., Pardoll D.M., Jacobson S., Schneck J.P. Direct visualization of antigen-specific T cells: HTLV-1 Tax11-19- specific CD8(+) T cells are activated in peripheral blood and accumulate in cerebrospinal fluid from HAM/TSP patients. Proc. Natl. Acad. Sci. U. S. A. 95:1998;7568-7573.
22. Gutgemann I., Fahrer A.M., Altman J.D., Davis M.M., Chien Y.H. Induction of rapid T cell activation and tolerance by systemic presentation of an orally administered antigen. Immunity. 8:1998;667-673.
23. Hamad A.R., O'Herrin S.M., Lebowitz M.S., Srikrishnan A., Bieler J., Schneck J., Pardoll D. Potent T cell activation with dimeric peptide-major histocompatibility complex class II ligand: the role of CD4 coreceptor. J. Exp. Med. 188:1998;1633-1640.
24. Kozono H., White J., Clements J., Marrack P., Kappler J. Production of soluble MHC class II proteins with covalently bound single peptides. Nature. 369:1994;151-153.
25. Langone J.J. Complexes containing Staphylococcus aureus protein A: composition and biological activity. J. Biol. Response Modif. 3:1984;241-246.
26. Langone J.J., Das C., Mainwaring R., Shearer W.T. Complexes prepared from protein A and human serum, IgG, or Fc gamma fragments: characterization by immunochemical analysis of ultracentrifugation fractions and studies on their interconversion. Mol. Cell. Biochem. 65:1985;159-170.
27. Lebowitz M.S., O'Herrin S.M., Hamad A.R., Fahmy T., Marguet D., Barnes N.C., Pardoll D., Bieler J.G., Schneck J.P. Soluble, high-affinity dimers of T-cell receptors and class II major histocompatibility complexes: biochemical probes for analysis and modulation of immune responses. Cell. Immunol. 192:1999;175-184.
28. Lone Y.C., Motta I., Mottez E., Guilloux Y., Lim A., Demay F., Levraud J.P., Kourilsky P., Abastado J.P. In vitro induction of specific cytotoxic T lymphocytes using recombinant single-chain MHC class I/peptide complexes. J. Immunother. 21:1998;283-294.
29. Luxembourg A.T., Borrow P., Teyton L., Brunmark A.B., Peterson P.A., Jackson M.R. Biomagnetic isolation of antigen-specific CD8+ T cells usable in immunotherapy. Nat. Biotechnol. 16:1998;281-285.
30. + T cells in resistant mice upon infection with Leishmania major. Immunity. 13:2000;771-782.
31. McMichael A.J., Kelleher A. The arrival of HLA class II tetramers. J. Clin. Invest. 104:1999;1669-1670.
32. Motta I., Lone Y.C., Kourilsky P. In vitro induction of naive cytotoxic T lymphocytes with complexes of peptide and recombinant MHC class I molecules coated onto beads: role of TCR/ligand density. Eur. J. Immunol. 28:1998;3685-3695.
33. O'Herrin S.M., Slansky J.E., Tang Q., Markiewicz M.A., Gajewski T.F., Pardoll D.M., Schneck J.P., Bluestone J.A. Antigen-specific blockade of t cells in vivo using dimeric mhc peptide. J. Immunol. 167:2001;2555-2560.
34. Scott C.A., Garcia K.C., Carbone F.R., Wilson I.A., Teyton L. Role of chain pairing for the production of functional soluble IA major histocompatibility complex class II molecules. J. Exp. Med. 183:1996;2087-2095.
35. Selin L.K., Lin M.Y., Kraemer K.A., Pardoll D.M., Schneck J.P., Varga S.M., Santolucito P.A., Pinto A.K., Welsh R.M. Attrition of T cell memory: selective loss of LCMV epitope-specific memory CD8 T cells following infections with heterologous viruses. Immunity. 11:1999;733-742.
36. Wang Q., Malherbe M., Zhang D., Zingler K., Glaichenhaus N., Killeen N. CD4 promotes breadth in the TCR repertoire. J. Immunol. 167:2001;4311.